Radiocontrast materials are tri-iodinated benzoic acid derivatives that in solution contain a small amount of free iodide. Non-idiosyncratic reactions to radiocontrast media are due to direct toxic or osmolar effects. The only adverse effect of contrast material that can convincingly be ascribed to free iodide is iodide mumps and other manifestations of iodism.
Idiosyncratic (including allergic) reactions
Immediate and non-immediate hypersensitivity-type reactions after contrast media are not common. However, contrast media are frequently used (estimated at 70 million administrations worldwide per year)3 and often in large volumes so reactions are an important problem. Immediate reactions consist of allergic-type manifestations such as pruritus, erythema, urticaria, angioedema and anaphylaxis. Non-immediate (more than one hour after administration) reactions are predominantly cutaneous and consist of urticaria, angioedema, maculopapular rash or rarely, more severe reactions such as Stevens-Johnson syndrome.3
Iodinated contrast media were formerly hypertonic and ionic solutions, whereas newer products are closer to isosmolarity and are non-ionic. The incidence of hypersensitivity-like reactions is much lower with non-ionic, low-osmolar contrast media. Anaphylaxis has been estimated to occur at a frequency of 0.1–0.4% with ionic and 0.02–0.04% with non-ionic contrast media.2 In the case of hyperosmolar and ionic contrast media, the predominant mechanism of the reaction is thought to be a direct non-immunological effect on mast cells and basophils or activation of the complement system. Severe reactions are associated with elevation of histamine and mast cell tryptase in the same way as allergic anaphylaxis. These reactions to contrast media were previously termed 'anaphylactoid', but the term 'nonallergic anaphylaxis' is now preferred.
There is growing evidence that a proportion of the rare cases of anaphylaxis to non-ionic contrast media is IgE-mediated, in other words, a true allergic anaphylaxis. Some research suggests that intradermal testing or in vitro IgE detection might be useful in these cases, but this is an evolving area. The role of the iodine atom (as a part of the iodinated molecular complex) in these cases is unknown. It is known, however, that none of 23 patients with documented contrast sensitivity reacted to subcutaneous sodium iodide.
Risk factors for hypersensitivity
A number of studies have shown that while patients with an allergy to seafood are at a slightly greater risk of reacting to contrast media, seafood allergy is not a specific risk factor. It is food allergy in general which increases the risk, as does severe hay fever or asthma, indicating that the atopic state is the risk factor, not seafood allergy itself. A large case-control study established that the presence of cardiovascular disease, asthma and the use of beta-blockers were risk factors for severe reactions. Although the odds ratio for anaphylaxis is between 7 and 20, the absolute risk in these patients remains relatively low.4 The presence of these risk factors alone should not be sufficient to contraindicate administration of contrast media, but should signal caution. The only substantial risk factor for severe immediate reactions to contrast media is a history of a previous severe reaction, but this may be a relative or absolute contraindication (see Table 1). Systemic mastocytosis is theoretically another significant risk factor. Whether these risk factors apply equally to ionic and non-ionic contrast media is not established, but non-ionic contrast media have a lower incidence of reactions in all of these cases.
Risk factors for non-immediate reactions are an elevated serum creatinine, a history of drug allergy or contact hypersensitivity, and previous non-immediate reactions. There is no evidence that previous non-immediate reactions to contrast media increase the risk of anaphylaxis to contrast media.
A history of contact allergy to iodinated antiseptics is not a specific contraindication to the administration of contrast media, but may slightly increase the risk of a non-immediate reaction to the same degree as any other contact hypersensitivity. A history of anaphylaxis to povidone-iodine does not contraindicate the use of contrast media because the structure of povidone, with or without iodine, is not similar to that of contrast media and cross-reactivity has not been demonstrated.
Table 1 Management of patients having contrast media
Risk factors
|
Management
|
None
|
Routine procedure*
|
Severe food allergy Moderate severe asthma Significant cardiovascular disease Beta blocker use
|
|
|
Close observation High-level preparedness Use non-ionic low-osmolarity contrast media if not routine
|
Previous mild moderate immediate reaction to contrast media
|
Premedication (see Box) Close observation High-level preparedness Use non-ionic low-osmolarity contrast media if not routine
|
Previous mild moderate non-immediate cutaneous reaction to contrast media
|
Premedication (see Box) Use non-ionic low-osmolarity contrast media if not routine†
|
Previous anaphylaxis to contrast media
|
Contrast media probably contraindicated‡
|
Previous severe non-immediate cutaneous reaction tocontrast media (e.g. vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis)
|
Contrast media contraindicated‡
|
* Always be prepared to treat unexpected allergic reactions (see Emergency management of anaphylaxis in the community: wall chart. Aust Prescr 2007;30:115)
|
Using contrast media in patients with risk factors
When preparing a patient for a procedure using contrast media, risk factor assessment should include asking about severe food allergy, drug allergy, asthma, cardiovascular disease or beta blocker use and previous reactions to contrast media. Management strategies in the presence of these risk factors might include:
- close observation and preparedness to treat a reaction
- giving low-osmolarity non-ionic contrast media (if this is not yet routine)
- premedication (see Box).
There are a number of case reports of premedication failing to prevent subsequent anaphylaxis,5 so in some cases contrast media should be avoided. Other diagnostic tests may be more suitable.
Box - Premedication
Cetirizine 10 mg
|
|
repeat after 12 hours
|
Prednisolone 25 mg
|
Ranitidine 150 mg
|
This regimen is given on the day before and on the day of the procedure. It is also given on the day after the procedure if there is a history of delayed reaction.
|